Abstract
Cancer recurrence is devastating for any patient, and challenging for the treating physician. Appropriate workup and optimal treatment at first diagnosis are the most important factors affecting chances of long term control. While inadequacies in delivery of standard treatment are important, there are many other factors like host and tumour biology that also influence the chance of recurrence. Recurrence may be loco-regional, distant or both, and treatment of these patients needs to be individualised.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–37.
Kamby C, Ejlertsen B, Andersen J, et al. The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival. Acta Oncol. 1988;27:715–9.
Kamby C, Vejborg I, Kristensen B, Olsen LO, Mouidsen HT. Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic recurrences. Cancer. 1988;62:2226–33.
Jeong Y, Kim SS, Gong G, et al. Treatment results of breast cancer patients with locoregional recurrence after mastectomy. Radiat Oncol J. 2013;31:138–46. https://doi.org/10.3857/roj.2013.31.3.138.
Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672–94.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast conserving surgery on 10-year recurrence and 15 year breast cancer death: meta-analysis of 17 randomized clinical trials. Lancet. 2011;378:1707–16.
Elfgen C, Schmid SM, Tausch CJ, Montagna G, Güth U. Radiological staging for distant metastases in breast cancer patients with confirmed local and/or Locoregional recurrence: how useful are current guideline recommendations? Ann Surg Oncol. 2019;26:3455–61. https://doi.org/10.1245/s10434-019-07629-9.
Sacchini V. Restaging patients with Locoregional relapse: is there any benefit? Commentary on “Radiological staging for distant metastases in breast cancer patients with confirmed local and/or locoregional recurrence: how useful are current guideline recommendations?” by Elfgen. Constanze et al Ann Surg Oncol. 2019;26:3415–7. https://doi.org/10.1245/s10434-019-07642-y.
Isasi CR, Moadel RM, Blaufox MD. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat. 2005;90(2):105–12. https://doi.org/10.1007/s10549-004-3291-7.
Piva R, Ticconi F, Ceriani V, et al. Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence. Breast Cancer (Dove Med Press). 2017;9:461–71. Published 2017 Jul 4. https://doi.org/10.2147/BCTT.S111098.
Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat. 2012;133(3):831–41. https://doi.org/10.1007/s10549-011-1891-6.
Ma J, Jiang R, Fan L, et al. Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era. Oncotarget. 2015;6:36860–9. https://doi.org/10.18632/oncotarget.5365.
Salvadori B, Marubini E, Miceli R, et al. Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg. 1999;86(1):84–7. https://doi.org/10.1046/j.1365-2168.1999.00961.x.
Yu C-C, Kuo W-L, Shen S-C, et al. Prognostic study for isolated local recurrence operated with salvage excision in hormone-receptor-positive patients with invasive breast cancer after primary breast surgery. Biom J. 2020;43:83–93. https://doi.org/10.1016/j.bj.2019.07.002.
Harms W, Geretschläger A, Cescato C, Buess M, Köberle D, Asadpour B. Current treatment of isolated locoregional breast cancer recurrences. Breast Care (Basel). 2015;10(4):265–71. https://doi.org/10.1159/000439151.
Belkacemi Y, Hanna NE, Besnard C, Majdoul S, Gligorov J. Local and regional breast cancer recurrences: salvage therapy options in the new era of molecular subtypes. Front Oncol. 2018;8:112. https://doi.org/10.3389/fonc.2018.00112.
Caswell-Jin JL, Plevritis SK, Tian L, et al. Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review. JNCI Cancer Spectr. 2018;2:pky062. https://doi.org/10.1093/jncics/pky062.
Kim H, Choi DH, Park W, et al. Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J. 2013;31:222–7.
Leung AM, Vu HN, Nguyen KA, et al. Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res. 2010;161:83.
Pagani O, Senkus E, Wood W, et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst. 2010;102:456.
Teshome M. Role of operative Management in Stage IV breast cancer. Surg Clin North Am. 2018;98:859–68.
Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16:1380.
King TA, Lyman JP, Gonen M, et al. Prognostic impact of 21-gene recurrence score in patients with stage IV breast cancer: TBCRC 013. J Clin Oncol. 2016;34:2359–65. https://doi.org/10.1200/JCO.2015.63.1960.
Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25:3141.
Harris E, Barry M, Kell MR. Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival. Ann Surg Oncol. 2013;20:2828.
Cady B, Nathan NR, Michaelson JS, et al. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol. 2008;15:3384.
NCCN guidelines Version 3.2019 Breast Cancer.
Van Poznak C, Somerfield MR, Bast RC, et al. Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2015;33:2695.
Cardoso F, Senkus E, Costa A, et al. 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4). Ann Oncol. 2018;29:1634.
Lindström LS, Karlsson E, Wilking UM, et al. Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol. 2012;30:2601.
Chua TC, Saxena A, Liauw W, et al. Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer. 2011;47:2282.
Bigorie V, Morice P, Duvillard P, et al. Ovarian metastases from breast cancer: report of 29 cases. Cancer. 2010;116:799.
Li W, Wang H, Wang J, et al. Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients. BMC Cancer. 2012;12:278.
Noble J, Sirohi B, Ashley S, et al. Sternal/para-sternal resection for parasternal local recurrence in breast cancer. Breast. 2010;19:350.
Selzner M, Morse MA, Vredenburgh JJ, et al. Liver metastases from breast cancer: long-term survival after curative resection. Surgery. 2000;127:383.
Maksan SM, Lehnert T, Bastert G, Herfarth C. Curative liver resection for metastatic breast cancer. Eur J Surg Oncol. 2000;26:209.
Sadot E, Lee SY, Sofocleous CT, et al. Hepatic resection or ablation for isolated breast cancer liver metastasis: a case-control study with comparison to medically treated patients. Ann Surg. 2016;264:147.
Pawlik TM, Izzo F, Cohen DS, et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003;10:1059.
Bortolotto C, Macchi S, Veronese L, et al. Radiofrequency ablation of metastatic lesions from breast cancer. J Ultrasound. 2012;15:199.
Planchard D, Soria JC, Michiels S, et al. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer. 2004;100:28.
Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg. 2002;22:335.
Yoshimoto M, Tada K, Nishimura S, et al. Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat. 2008;110:485.
Meimarakis G, Rüttinger D, Stemmler J, et al. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer. Ann Thorac Surg. 2013;95:1170.
Briasoulis E, Karavasilis V, Kostadima L, et al. Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Cancer. 2004;101:1524.
Alvarado-Cabrero I, Rodríguez-Gómez A, Castelan-Pedraza J, Valencia-Cedillo R. Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytopathol Histpathol. 2013;35:241.
Quan ML, Fey J, Eitan R, et al. Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer. Gynecol Oncol. 2004;92:327.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Saini, S., Pattanayak, M., Arora, A. (2022). Recurrent Breast Cancer (Local and Metastatic): Surgical Aspects. In: Sharma, S.C., Mazumdar, A., Kaushik, R. (eds) Breast Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-16-4546-4_17
Download citation
DOI: https://doi.org/10.1007/978-981-16-4546-4_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-4545-7
Online ISBN: 978-981-16-4546-4
eBook Packages: MedicineMedicine (R0)